Guardant Health Financial Statements
NASDAQ: GHHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Guardant Health revenue and earnings
In fiscal 2025, Guardant Health generated $982.0 million in revenue, up 32.9% from fiscal 2024, its 8th consecutive year of revenue growth. Guardant Health reported a net loss of $416.3 million, compared with a loss of $436.4 million a year earlier. Gross margin was 64.5% (up from 60.8%) and operating margin -44.5%.
Diluted earnings per share came in at -$3.32. Over the last 5 fiscal years, GH's revenue has grown at a 27.9% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Guardant Health income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 982.02M | 739.02M | 563.95M | 449.54M | 373.65M | 286.73M | 214.38M | 90.64M | 49.84M |
| Revenue growth (YoY) | +32.88% | +31.04% | +25.45% | +20.31% | +30.32% | +33.75% | +136.52% | +81.85% | — |
| Cost of Revenue | 349.01M | 289.80M | 227.05M | — | — | — | — | — | — |
| Gross Profit | 633.01M | 449.22M | 336.90M | — | — | — | — | — | — |
| Operating Expenses | 1.07B | 892.81M | 901.62M | — | — | — | — | — | — |
| Research & Development | 364.19M | 347.75M | 367.19M | 373.81M | 263.22M | 149.86M | 86.29M | 50.71M | 25.56M |
| Selling, General & Admin | 706.07M | 545.06M | 451.03M | 463.78M | 398.52M | 299.28M | 139.73M | 89.66M | 69.27M |
| Operating Income | -437.25M | -443.59M | -564.73M | -544.38M | -411.00M | -254.95M | -82.37M | -92.94M | -76.61M |
| Interest Expense | 3.90M | 2.58M | 2.58M | 2.58M | 2.58M | 4.77M | 1.18M | 1.25M | 2.70M |
| Other Income (Expense) | -10.49M | -42.60M | 53.17M | -12.78M | 25.18M | 3.64M | 88.00K | 4.70M | -1.06M |
| Pretax Income | -417.54M | -435.09M | -478.76M | -653.45M | -384.47M | -245.90M | -69.72M | -84.22M | -83.21M |
| Income Tax | -1.26M | 1.28M | 685.00K | 1.14M | 300.00K | 379.00K | -1.87M | 38.00K | 7.00K |
| Net Income | -416.28M | -436.37M | -479.45M | -654.59M | -384.77M | -246.28M | -75.65M | -85.06M | -83.22M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -3.32 | -3.56 | -4.28 | -6.41 | -4.00 | -2.60 | -0.84 | -2.80 | -7.07 |
| EPS (Diluted) | -3.32 | -3.56 | -4.28 | -6.41 | -4.00 | -2.60 | -0.84 | -2.80 | -7.07 |
| Shares Outstanding (Basic) | 125.37M | 122.75M | 111.99M | 102.18M | 101.31M | 97.50M | 90.60M | 30.40M | 12.58M |
| Shares Outstanding (Diluted) | 125.37M | 122.75M | 111.99M | 102.18M | 101.31M | 97.50M | 90.60M | 30.40M | 12.58M |
| EBITDA | -397.51M | -401.21M | -521.84M | -508.42M | -388.73M | -238.88M | -70.96M | -85.81M | -71.41M |
| Gross Margin | 64.46% | 60.79% | 59.74% | — | — | — | — | — | — |
| Operating Margin | -44.53% | -60.02% | -100.14% | -121.10% | -110.00% | -88.92% | -38.42% | -102.54% | -153.71% |
| Net Margin | -42.39% | -59.05% | -85.02% | -145.61% | -102.98% | -85.89% | -35.29% | -93.85% | -166.97% |
This table shows 9 annual periods of Guardant Health's income statement, from FY 2025 back to FY 2017, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow GH's reporting calendar. What is a income statement?